01-Feb-15 Over ten years the Global Fund initiative in China has successfully addressed several major public health problems. Access to diagnosis and treatment of tuberculosis expanded from two pilot projects in 2006 to 92 sites in 30 provinces by 2013. Between 2002 and 2012 the number of malaria cases fell from over 100,000 to less than 5,000. Finally, China's rate of HIV infection was stabilised at 0.06%. [image: Snipview]

30-Jan-15 China's mobile healthcare market is expected to see fast growth and hit 12.5 billion yuan (USD2 billion) by 2017, according to the China Medical Pharmaceutical Material Association. There are already more than 2,000 mobile healthcare applications in China and 527 million mobile Internet users. [image: mHealthWatch]

25-Jan-15The Chinese pharmaceutical sector saw lower growth in 2014 due to a host of challenges including slowing overall economic growth, regulatory shakeups, cost containment measures and price cuts, as well as healthcare reform turbulence. However, the market is still estimated to have grown 13% in 2014, to reach USD200 billion. [image: My Jungle Blog]

For more about China's healthcare sector, request our free 20-page whitepaper: China Healthcare Market Opportunities

09-Jan-15 The China Food and Drug Administration (CFDA) plans to allow online sales of prescription drugs soon. If approved, the policy could seed a market worth more than USD160 billion as sales shift from hospitals to online platforms such as Alibaba and JD.com. [image: Reuters/Stringer]

14-Jan-15 Overall, the Chinese government created lots of space for the private sector in 2014, meaning demand remained strong and companies benefited. This trend is likely to continue in 2015, especially if initiatives such as online drug sales, foreign participation in health services, and more funding for doctors’ pay, CFDA and telemedicine, are continued. [image: Forbes]